Оригинальный отечественный противоопухолевый препарат лизомустин
Lysomustine (Nitrullin, CRC 680578) is a new highly effective antitumor drug elaborated at the Institute of Organic Synthesis of the Ural Division of RAS (Ekaterinburg) and Russian Cancer Research Center (Moscow). Lysomustine is easily endurable and exhibits high activity against malignant melanoma, lymphosarcoma and lung carcinoma. Lysomustine has been considered to be appropriate for use in treatment of both seriously ill and elderly patients, and out-patients.
Ключевые слова:
